Clinical Research
corporate_fare

Granular Therapeutics Limited

Address
Innovation House, Innovation Way, Discovery Park

Sponsor Overview

assignment
1
sponsored trial
science
0
molecules
location_city
7
research centres
public
1
country
person_search
8
investigators

Specializations

Allergic and Inducible Skin Disorders

Granular Therapeutics Limited focuses on chronic inducible urticaria, with particular interest in cold induced urticaria and related forms of recurrent wheal-and-flare skin reactivity.

  • Cold induced urticaria
  • Chronic inducible urticaria
  • Cutaneous hypersensitivity

The sponsor’s clinical activity is centred on conditions marked by trigger-related urticarial symptoms and their impact on daily functioning.

Immunology and Mast Cell-Driven Symptoms

The company’s research interest extends to immune-mediated mechanisms involved in hives, itching, swelling, and other mast cell-associated manifestations.

  • Histamine-mediated responses
  • Pruritus
  • Angioedema

Its clinical portfolio reflects attention to the biological pathways underlying trigger-sensitive skin inflammation.

Symptom Control and Patient Tolerability

Granular Therapeutics Limited is active in research addressing the control of urticaria-related symptoms and the tolerability of treatments intended for people living with recurrent episodes.

  • Symptom relief
  • Treatment tolerability
  • Patient-reported outcomes

This area of interest includes clinical evaluation in both healthy volunteers and patients with chronic inducible urticaria.

Translational Dermatology

The sponsor’s research landscape includes early clinical investigation in dermatology, linking mechanistic understanding of trigger-induced skin reactions with therapeutic development.

  • Wheal formation
  • Flare responses
  • Inducible skin reactivity

Its work is directed toward medical areas where environmental triggers provoke reproducible cutaneous symptoms.

Sponsored Trials

Trial Name Country Status
Phase 1 Randomized Double-Blind Placebo-Controlled Study of GTX-B001 in Cold Induced Urticaria and Healthy VolunteersGermany GermanyRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)

This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 7 sites collaborated multiple times

This sponsor has worked with 7 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Skin and Connective Tissue Diseases1 trial
    247 other sponsors

Partnered Research Centres

7 centres
location_city
assignment518
Center For Pediatric And Adolescent Medicine Of The Johannes Gutenberg University Mainz
Address
Langenbeckstrasse 1, Oberstadt, 55131 Mainz
Learn morearrow_forward
location_city
assignment134
Charite Research Organisation GmbH
Address
Chariteplatz 1, 10117 Berlin
Learn morearrow_forward
location_city
assignment1047
Charite Universitaetsmedizin Berlin KöR
Address
Hindenburgdamm 30, Lichterfelde, 12203 Berlin
Learn morearrow_forward
location_city
assignment2
Dermatologische Praxis Dr. med. Abdou Zarzour
Address
Grosse Steinstrasse 12, 06108 Halle
Learn morearrow_forward
location_city
assignment278
Justus-Liebig-Universitaet Giessen
Address
Klinikstrasse 33, 35392 Giessen
Learn morearrow_forward
location_city
assignment533
Universitaetsklinikum Muenster AöR
Address
Von-Esmarch-Strasse 58, Sentrup, 48149 Munster
Learn morearrow_forward
Page 1 of 2

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Granular Therapeutics Limited.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.